© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

Transition finance in transition — companies face investors in flux

Demand to invest in the low carbon transition is growing fast, but strategies are very diverse
Issuance net of buy-backs is not that high, and there is no sign of any indigestion

Caffil lands social covered bond as market ‘comes off the boil’

◆ Order book smaller than issuer’s last covered in January ◆ Banker said covered bond market has reached plateau ◆

AI impact fear rocks IPO hopefuls

Questions hang over the future of software as a service firms
Issuance net of buy-backs is not that high, and there is no sign of any indigestion
Sub-sections
  • Fresenius, the German healthcare company, pushed ahead with a €1bn dual tranche no-grow trade on Monday, despite an issuer in another sector pulling its deal as wider markets plummeted.
  • German hospital operator Asklepios Kliniken launched a Schuldschein on Monday with an initial target of €200m. Investors have doubled down on their interest in pharmaceutical firms this year and throughout the pandemic, prompting a substantial increase in the market’s exposure to the sector.
  • Rolls-Royce, the UK maker of aircraft engines, has confirmed it is considering holding a £2.5bn ($3.19bn) equity raise, but buy-side sources were struggling to make the investment case for the company given the uncertainty over its future. Its stock fell 10% on Monday on the announcement and fears that the UK will return to a lockdown to stop the dramatic rise in Covid-19 cases.